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Abstract
Background: Highly pathogenic avian influenza (HPAI) viruses pose a potential human health threat as they can be
transmitted directly from infected poultry to humans. During a large outbreak of HPAI H7N7 virus among poultry in
The Netherlands in 2003, bird to human transmission was confirmed in 89 cases, of which one had a fatal outcome.
Methods: To identify genetic determinants of virulence in a mammalian host, we passaged an avian H7N7/03
outbreak isolate in mouse lungs and evaluated the phenotype of the mouse-adapted variant in animal models and
in vitro.
Results: Three passages in mouse lungs were sufficient to select a variant that was highly virulent in mice. The virus
had a MLD50 that was >4.3 logs lower than that of its non-lethal parental virus. Sequence analysis revealed a single
mutation at position 627 in PB2, where the glutamic acid was changed to a lysine (E627K). The mouse-adapted
virus has this mutation in common with the fatal human case isolate. The virus remained highly pathogenic for
chickens after its passage in mice. In ferrets, the mouse-adapted virus induced more severe disease, replicated to
higher titers in the lower respiratory tract and spread more efficiently to systemic organs compared with the
parental virus. In vitro, the PB2 E627K mutation had a promoting effect on virus propagation in mammalian, but
not in avian cells.
Conclusions: Our results show that the E627K mutation in PB2 alone can be sufficient to convert an HPAI H7N7
virus of low virulence to a variant causing severe disease in mice and ferrets. The rapid emergence of the PB2
E627K mutant during mouse adaptation and its pathogenicity in ferrets emphasize the potential risk of HPAI H7N7
viruses for human health.
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Background
Highly pathogenic avian influenza (HPAI) viruses are the
cause of a highly contagious and often fatal disease of
poultry. Their pathogenicity is determined by the presence
of multiple basic amino acids at the cleavage site of the
HA protein, which renders HA susceptible to cleavage by
furin-like host proteases [1-3]. The HA of avian influenza
viruses mediates attachment of the virus to the cell
through interaction with α2,3-linked sialic acid (SIA)
receptors [4,5]. Avian influenza viruses do not usually
infect humans, because epithelial cells in the upper
respiratory tract of humans predominantly carry SIAs
with α2,6 linkages [6]. During the epidemic caused by
HPAI H5N1 viruses on the Asian continent, it became
evident that these viruses could be transmitted directly
from bird to human despite their preference for avian-type
a2,3 SIA receptors [7]. In addition to HA, other viral
proteins, notably polymerase proteins, are now recognized
as determinants of host range and virulence of HPAI
viruses in mammalian species (reviewed in [8]).
In 2003, the poultry industry in The Netherlands was
hit by an outbreak of HPAI H7N7 virus, leading to the
death and culling of more than 30 million birds [9].
Sero-epidemiological survey indicated that at least 89* Correspondence: Lisette.cornelissen@wur.nl
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persons had become infected by the time the epidemic
ended [10]. Infected persons displayed signs of conjunc-
tivitis and sometimes mild flu-like disease. One person
became seriously ill and ultimately died from respiratory
complications. Sequence analysis revealed 14 amino acid
differences between the virus isolated from this fatal case
(A/Netherlands/219/03) and the prototype chicken isolate
(A/ch/Netherlands/1/03) [11]. One of those was present
at position 627 of the PB2 protein, where the glutamic
acid was substituted by a lysine (E627K). The PB2 E627K
mutation distinguished the A/Netherlands/219/03 virus
from other avian and human H7N7/03 outbreak isolates
[12,13]. PB2 and the other viral polymerase proteins, PB1
and PA, form the polymerase complex of influenza viruses,
which, along with NP, regulates replication and transcrip-
tion of the viral genome [14,15]. Residue 627 of PB2 has
been identified as an important determinant of host range
and pathogenicity of avian influenza viruses in a mamma-
lian host [16-20]. Studies in mice confirmed that this is also
the case for H7N7/03 viruses. The A/Netherlands/219/03
virus was shown to be highly lethal to mice, in contrast to
an H7N7/03 isolate obtained from a human conjunctivitis
case (A/Netherlands/33/03). When 627K was introduced
into PB2 of A/Netherlands/33/03, the virus acquired a
lethal phenotype, whereas A/Netherlands/219/03 became
low-virulent after introduction of glutamic acid at this
position [21]. Pathogenicity studies with A/Netherlands/
219/03 virus in ferrets also suggested an important role
for PB2 627K, but a contribution of additional mutations
in the genome was not excluded [22].
Although valuable data on virological aspects of H7N7/03
outbreak viruses have since become available [21,23],
there is still little information on the molecular changes
required for host adaptation and enhanced virulence of
HPAI H7N7 viruses in mammals. Sequencing of avian
viral isolates indicated that human adaptation markers
evolved in poultry [12,23], but ‘the impact of these specific
mutations for public health risk is yet uncertain’ [13].
Ferrets are considered suitable to predict the outcome
of influenza virus infection in humans, because they have,
unlike mice, predominantly human-type α2,6-linked SIA
receptors in their upper respiratory tract [24-26]. Another
advantage of this model is that ferrets exhibit clinical signs
of influenza disease similar to humans [27]. The mouse
can serve as a convenient mammalian model to study in a
laboratory setting the molecular changes arising during
adaptation of influenza viruses to a new host [24,28].
Serial lung passages in mice have been used to identify
mutations that are critical for host change and enhanced
virulence in mammals [29-31]. Such mouse adaptation
experiments with H7N7/03 viruses have not been reported
before. Here, we performed a mouse-adaptation experi-
ment, in which one of the HPAI H7N7/03 chicken isolates,
A/ch/Netherlands/621557/03, was serially passaged in
mouse lungs. We then compared the virulence of the
mouse-adapted variant with that of the parental chicken
virus using the mouse and ferret as mammalian models.
Our results show that three passages in mice were sufficient
to select a PB2 E627K mutant that was highly lethal to
mice and displayed enhanced pathogenicity in ferrets.
Results
Adaptation of chicken H7N7/03 virus to mice
Previously, we had observed that the A/ch/Netherlands/
621557/03 isolate (designated as chH7N7 virus) was not
lethal for mice, even at a dose of 106 TCID50 (unpublished
observations). To increase its virulence in mice (BALB/c),
the chH7N7 virus was repeatedly passaged in mouse lungs.
On day 4 of each passage, the lungs were harvested and
virus titers determined in pooled lung homogenates. The
initial infection with chH7N7 virus yielded a titer of 106.5
TCID50/g tissue. Virus titers increased during subsequent
passages to 108.0 TCID50/g at the second passage (P2)
and 108.5 TCID50/g at the third passage (P3). Following
inoculation of the P3 lung suspension, all 3 extra mice
tested became ill and died 7 days after infection (data
not shown).
Virulence of mouse-adapted H7N7/03 virus in mice
and chickens
The virus present in pooled lung homogenate after 3
passages was propagated in embryonated chicken eggs to
prepare the maH7N7 virus stock, which was subsequently
used to assess the virulence of the mouse-adapted variant
in mice. For this purpose, groups of 10 BALB/c mice were
inoculated with increasing doses of maH7N7 virus. For
comparison, two groups of 10 mice were inoculated with
different doses of chH7N7 virus. The percentages of
survival and mean body weights per group observed
after infection are shown in Figure 1. Mice inoculated
with 106 TCID50 of chH7N7 virus showed considerable
weight loss, but all survived. When a dose of 103 TCID50
was given, one mouse died on day 13 post infection (p.i.),
but all other mice survived without showing weight loss
or other signs of disease. In contrast, mice inoculated with
the same dose of maH7N7 virus began to lose weight soon
after infection and all died 7 to 9 days later. Even with a
dose as low as 50 TCID50 of maH7N7, 50% of the mice
died. Thus, three mouse passages selected a virus with a
MLD50 titer that was at least 4.3 logs lower than that of
the chH7N7 virus (assuming that the MLD50 of the
chH7N7 virus was higher than 106 TCID50).
Based on the standard OIE test, avian influenza viruses
with an intravenous pathogenicity index (IVPI) in 6-week-
old chickens greater than 1.2 (out of a possible maximum
of 3.0) are considered highly pathogenic. The chH7N7 virus
had an IVPI of 2.9 [32]. We examined the pathogenicity of
the maH7N7 virus in chickens following respiratory tract
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exposure by inoculating virus via the combined intranasal
and intratracheal (IN/IT) route. The results indicated that
the PB2 E627K mutant was lethal for chickens. Similar to
what was previously observed after IN/IT administration
of the chH7N7 virus [32], inoculation of maH7N7 virus
resulted in rapid death of the birds; one chicken died
on day 2 and the other 4 chickens died on day 3 p.i.,
corresponding with an IN/IT pathogenicity index of 2.6.
Sequence analysis
We sequenced the entire genome of both viruses and
found that the maH7N7 virus differed from the chH7N7
virus by only one amino acid at position 627 of PB2,
where glutamic acid was changed into a lysine (E627K).
Subsequent sequence analysis of the PB2 gene of virus
present in P3 lung homogenates confirmed the presence
of PB2 E627K. The PB2 sequence of virus from the P2
lung homogenate revealed that 627E was substituted
already after the second mouse passage. Table 1 shows
the amino acid sequence of the chicken virus selected
for this study compared to that of other human and
avian H7N7/03 viruses. The chH7N7 virus differed from
the A/ch/Netherlands/1/03 prototype at only one position
in NA (T164N). The maH7N7 and A/Netherlands/219/03
viruses had 14 amino acid differences, but shared the
627K in PB2.
Growth of H7N7/03 viruses in cell culture
In vitro growth of maH7N7 and its parental virus was
assessed by analysis of plaque formation in cell cultures.
As shown in Figure 2A and B, infection of MDCK cells
with maH7N7 virus resulted in plaques that were 2.7-fold
larger than those of the chH7N7 virus. The maH7N7 virus
produced larger plaques (2.2-fold) also in monkey kidney-
derived VERO cells. No difference in plaque size between
the maH7N7 and chH7N7 viruses was observed in QM5
cells, a quail myogenic cell line [33]. When the replication
kinetics of both viruses were examined, we found that the
maH7N7 virus replicated faster than the chH7N7 virus in
MDCK cells, yielding titers that were 1.6 logs higher at 24
and 32 h p.i. (Figure 2C). However, the maH7N7 and
chH7N7 viruses produced similar growth curves in QM5
cells (Figure 2D), which was consistent with their plaque
phenotypes. These results indicate that the maH7N7 virus
was more efficient at replicating in mammalian cells than
the chH7N7 virus.
Pathogenicity of H7N7/03 viruses in ferrets
Next, we examined whether the PB2 E627K mutation in
the chicken virus also had an effect on its pathogenicity
in ferrets. To this end, two groups of 7 ferrets each were
inoculated with 107.4 TCID50 of maH7N7 or chH7N7
virus and one group was mock-infected. In each group,
3 animals were euthanized on day 5 p.i. for post mortem
examination; the other 4 animals were monitored for
clinical signs and body weight during 14 days after infec-
tion. From day 3 onwards, clinical signs were observed
in maH7N7-infected ferrets, including lethargy, sneezing
and respiratory distress. These symptoms were also
observed in ferrets infected with chH7N7 virus, but
were generally milder, had a later onset and the animals
recovered earlier (Figure 3A and B). Furthermore, ferrets
in the maH7N7-infected group displayed loss of appetite
from day 6 to 9 p.i., whereas reduction of food intake was
reported only on day 7 p.i. for the chH7N7-infected
group. All chH7N7-infected ferrets survived (Figure 3C).
Of the ferrets infected with maH7N7 virus, two needed to
be euthanized (one on day 11 and 12 each) because of
severe illness; one animal exhibited severe lethargy (a score
of 3), weakness and trembling, while the other was per-
sistently lethargic (a score of 2 for 8 days). Ferrets in
the chH7N7 group lost maximal ~5% of their initial
body weight, whereas those in the maH7N7 group lost
maximal ~9% of their weight (Figure 3D). On day 14 p.i.,
one chH7N7-infected animal showed a sudden drop in
body weight, but no severe signs of disease or pathological
changes in the lungs. Mock-infected animals did not show
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Figure 1 Virulence of H7N7/03 viruses in mice. Groups of 10
BALB/c mice were inoculated i.n. with maH7N7 or chH7N7 virus at
the indicated dose (TCID50). Clinical signs and body weights were
monitored daily until day 14 p.i. A) Kaplan-Meier survival curves,
indicating the percentage of survivors over time. B) Body weight
changes relative to the initial weight on day 0 (day of inoculation).
Error bars indicate the standard deviations.
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Table 1 Comparison of amino acid sequences of different H7N7/03 viruses
Amino acid identity at indicated positiona
Virus PB2 PA HA NA NS
79 297 355 563 627 666 13 143 416 164 308 346 442 458 126 137
A/ch/1/03 S V R Q E F I A K T N A T P K V
chH7N7 . . . . . . . . . N . . . . . .
maH7N7 . . . . K . . . . N . . . . . .
A/33/03b . . . . . . . . . . . . . . R .
A/219/03c I I K R K L S T R . S V A S . I
aAmino acids are indicated by single letters; dots represent amino acids identical to the A/ch/Netherlands/1/03 (A/ch/1/03) prototype [11].
bInfluenza A/Netherlands/33/03, isolated from human conjunctivitis case [11].
cInfluenza A/Netherlands/219/03, isolated from fatal human case [11].
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Figure 2 Growth of H7N7/03 viruses in cell culture. A) Plaque formation. MDCK, VERO or QM5 cells were infected with ~50 PFU of
virus and stained with amido black after 7 days of incubation. B) Quantification of plaque size in MDCK, VERO and QM5 cells. The mean
plaque size (measured in mm2) of chH7N7 is plotted relative to that of maH7N7 (set at 100%). Error bars represent the standard
deviations. The asterisk indicates significant difference in mean plaque size (P < 0.05). C, D) Growth kinetics of H7N7/03 viruses. MDCK
(C) or QM5 cells (D) were infected with chH7N7 or maH7N7 virus at an m.o.i. of 0.001 TCID50 per cell. Culture supernatants were
harvested at 8, 24, 32, 48 and 72 h p.i. and virus titers were determined by end-point titration in MDCK cells. Shown are means from
duplicate experiments with error bars indicating standard deviations. The dotted line indicates the lower limit of virus detection.
Undetectable titers were assigned a value of 1.3.
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any signs of disease and gained weight over time. All
chH7N7 and maH7N7 virus-infected ferrets exhibited H7
hemagglutination inhibiting (HI) antibody titers (geometric
mean titers of 420 and 680, respectively) on day 14 p.i.
Pathological examination of the lungs at day 5 p.i.
revealed foci of consolidation in two chH7N7-infected
ferrets in 1 or 2 lobes affecting ~1 or 3% of lung tissue
(Table 2). Comparable lesions were observed in all three
maH7N7-infected animals in 1 to 3 lobes affecting ~3 to
5% of lung tissue. Histopathological changes in the lungs
were similar in character in both infection groups; however,
the lesions were more severe and affected a greater
percentage of tissue in lungs infected with maH7N7 virus
than in lungs infected with chH7N7 virus (Figure 3E).
The lungs of maH7N7-infected ferrets showed alveolar
hemorrhages, infiltrations of granulocytes, lymphocytes and
histiocytes in the alveoli, and necrotizing bronchiolitis
with obliteration of bronchioli. No histopathological changes
were found in other organs, except in one chH7N7-
infected animal, which had foci of mononuclear cell infil-
trates in the liver.
Gross pathology at the end of the study revealed that, in
the lungs of three of four animals infected with chH7N7
virus, foci of consolidation were present in 1 or 2 lobes,
involving ~1 to 3% of lung tissue (Table 2). Multifocal to
coalescing consolidated areas were observed in 5 or 6
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Figure 3 Pathogenicity of H7N7/03 viruses in ferrets. Ferrets were inoculated i.n. with 107.4 TCID50 of either maH7N7 or chH7N7 virus. As
negative control, one group of ferrets was mock-infected. On day 5 p.i., 3 of the 7 animals per group were euthanized for post mortem
examination. The remaining animals were monitored for clinical signs and body weight changes during 14 days p.i. A) Median scores for
lethargy. B) Median scores for sneezing (if a ferret was euthanized, the last assigned score was carried forward). C) Kaplan-Meier survival curves.
D) Mean body weight changes relative to baseline weights at day 0. Only 2 ferrets of the maH7N7 group remained on day 13 p.i. Error bars
represent standard deviations. E, F) Semi-quantitative scoring of histopathological changes in lung tissues. Microscopic lung changes were scored
on a scale of 0 to 5 as detailed in the Methods section. Each point represents the histology score of an individual animal and horizontal bars
represent the median group scores. Lungs were examined E) on day 5 and F) on day 14 p.i. or when an animal needed to be euthanized before
the end of the study period (one on day 11 and 12 each, shown with open circles).
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lobes in total affecting ~25 to 30% of the lungs of the two
fatal cases of maH7N7 infection and in 3 lobes with ~10%
lung tissue affected in one of the two surviving animals of
this group. Histopathology of lungs of ferrets infected with
chH7N7 virus revealed only a few, small areas with atelec-
tasis or slight interstitial pneumonia, sometimes with mild,
focal bronchitis. Lesions were more severe and extended
to larger areas in the lungs of ferrets infected with maH7N7
virus (Figure 3F). In these lungs, we observed multifocal,
interstitial pneumonia, alveolar hyperplasia, peribronchitis
and, particularly in the two fatal cases, fibrinous alveolar
exudate with many mononuclear cells. There was slight to
moderate infiltration of lymphocytes and histiocytes in
liver tissues from animals of both infection groups.
Focal lymphohistiocytic encephalitis was seen in both fatal
cases of maH7N7 infection. No pathological changes were
detected in organs of the mock-infected controls. In
conclusion, the maH7N7 virus generally induced more
severe disease with more extensive lung pathology than
did the chH7N7 virus.
Replication of H7N7/03 viruses in ferrets
Nasal washes were collected from ferrets on alternate
days from day 1 to 9 p.i. and tested for the presence of
virus. The nasal wash titers of the maH7N7 and chH7N7
viruses were comparable until day 5 p.i. (range, 4.3 - 5.9
TCID50/ml; Figure 4A). The chH7N7 virus was no longer
detected or shed only at low level by day 7 p.i. At this time
point, maH7N7 virus continued being shed with a mean
titer that was 2.4 logs higher than that of the chH7N7
virus (range, 3.3 - 5.8 TCID50/ml).
After necropsy on day 5 p.i., viral loads were determined
in respiratory tissues and other organs. The results are
shown in Figure 4B and Table 3. Virus was detected in all
nasal turbinate samples with similar mean titers for both
viruses, although only two samples could be tested in the
chH7N7 group. Viral titers in the trachea and lungs of
ferrets infected with maH7N7 virus tended to be higher
(2 and 2.5 logs on average, respectively) than those mea-
sured after infection with chH7N7 virus. In two of three
maH7N7-infected ferrets, virus was detected in multiple
organs, including the intestines, kidney, spleen, liver, heart
and brain, indicating systemic infection. Infectious chH7N7
virus was recovered only from the respiratory tract, except
in one animal, which had a virus titer in the brain. The
recovery of chH7N7 from the brain, and not from other
extra-respiratory organs, of one animal is consistent with
previous observations [21,22] and was suggested to be due
to virus ascending via sensory nerves directly from the nose
to the brain and not the result of systemic virus distribution
[34,35]. Since olfactory bulb tissues were not sampled
separately, this could not be confirmed.
Discussion
The high incidence of human infections during the Dutch
epidemic in 2003, including one fatal case, has raised
concerns regarding the potential risk of HPAI H7N7 viruses
to human health. To identify molecular changes that are
critical for host adaptation and pathogenicity of these
viruses in mammals, we generated a mouse-adapted
variant of one of the avian H7N7/03 viruses isolated at
the earliest stage of the 2003 outbreak and evaluated its
phenotype in animal models and in vitro.
Mouse passaging rapidly gave rise to a variant that
differed from its avian parent only by the PB2 E627K
mutation. The mouse-adapted variant has this mutation in
common with the A/Netherlands/219/03 virus, indicating
that experimental adaptation of the H7N7/03 virus to mice
selected the same mutation as occurred during adaptation
to humans under natural conditions. The PB2 E627K
mutant was significantly more virulent for mice than its
non-lethal parental virus (> 4.3 logs decrease in MLD50
value). A dose of 103 TCID50 resulted in 100% lethality,
which was in agreement with the lethality observed for
the A/Netherlands/219/03 virus [21,22]. Evaluation of both
viruses in ferrets revealed that the maH7N7 virus generally
caused more severe disease with more pronounced lung
pathology, necessitating euthanasia of two of the four
animals. Although mean viral titers in the upper respiratory
tract were initially not markedly different, the mouse-
adapted virus was shed for one day longer. The virus
exhibited clear replicative advantage over the chH7N7
virus in the lower respiratory tract and spread more
efficiently to systemic organs. The contribution of PB2
627K to pathogenicity of the A/Netherlands/219/03 virus
has previously been demonstrated in mice [21]. Our results
Table 2 Gross pathology in lungs of ferrets infected with H7N7/03 virus
Gross pathological lung lesions on indicated time p.i.
Day 5 End of the studya
Virus No. of animalsb No. of lobes Area affected (%) No. of animals No. of lobes Area affected (%)
chH7N7 2/3 1, 2 1, 3 3/4 1, 1, 2 1, 3, 3
maH7N7 3/3 1, 2, 3 3, 3, 5 3/4 3, 5, 6 10, 25, 30
mock 0/3 x x 0/4 x x
aOn day 11 and 12 for the two fatal cases, on day 14 for all survivors.
bNumber of animals with gross lung pathology/total number of animals.
x = no pathological findings.
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show that mouse adaptation of HPAI H7N7 virus is driven
by PB2 and that PB2 E627K is an important virulence
factor of the virus not only in mice, but also in ferrets.
Viral growth performances in cultured cells correlated
with the pathogenicity or level of virus replication observed
in the animal models. The maH7N7 virus showed growth
characteristics comparable to that of the parental virus in
cells of avian origin and retained intranasal pathogenicity
in chickens; however, it grew with greater efficiency in
MDCK (canine) and VERO (monkey) cells and replicated
to higher titers in lungs of mice and ferrets. Others have
already shown that, in agreement to observations for other
influenza subtypes, PB2 627K in A/Netherlands/219/03
had a promoting effect on virus replication in mammalian
cells by increasing the activity of the avian polymerase [23].
As the PB2 sequence of the maH7N7 virus is identical to
that of A/Netherlands/219/03 (Table 1), we conclude that
maH7N7 pathogenicity in the mouse and ferret models
solely resulted from the increased potential of the adapted
PB2 polymerase to replicate in cells from different
mammalian species.
Previous work has shown that mutation A143T in HA
induced enhanced replication and tissue distribution, but
not pathogenicity, of the A/Netherlands/219/03 virus in
mice. This mutation, adding a potential glycosylation site
at position 141, was found responsible for a change in SIA
receptor specificity from exclusively α2,3 to both α2,3 and
α2,6 linkages [21,23]. Altered receptor binding properties
of HA seemed not to be critical for virulence and systemic
spread of the maH7N7 virus in ferrets, given the fact
that the chicken virus used in our study binds only to
α2,3-linked SIAs [23] and its adaptation to mice was
not accompanied by changes in HA. In this regard, the
maH7N7 virus shows similarity to the HPAI A/Vietnam/
1203/04 H5N1 virus that also spread to different organs
in ferrets despite having avian-type SIA specificity. It
was suggested that reduced ability to attach to mammalian
host cells can be compensated by more efficient replica-
tion of the genome by PB2 627K, resulting in higher yield
of progeny virus in an infected cell [36].
De Wit and co-workers [23] used in vitro systems to
investigate the molecular basis of differences in patho-
genicity between the human A/Netherlands/219/03 and
A/Netherlands/33/03 viruses. They found that, in addition
to PB2 E627K and HA A143T, amino acid substitutions
in PA (F666L) and NA (N308S, A346V, T442A and
P458S; Table 1) accounted for enhanced replication of
A/Netherlands/219/03 virus in human cells, suggesting a
causal link to adaptation and fatal disease in the human
host. Genetic analysis of a large panel of outbreak viruses
isolated from poultry revealed that, with the exception of
PB2 E627K, these amino acid substitutions were already
present in poultry viruses [12,23] and obviously did not
result from human adaptation. It is noteworthy that the
chicken isolate used in our study did not have any of these
substitutions or other known potential virulence/human
adaptation markers [13,30]. Yet, the virus was able to
establish a productive infection in ferrets, yielding sub-
stantial titers, while the PB2 E627K substitution appeared
to be sufficient for induction of severe disease. These ob-
servations suggest that HPAI H7N7 viruses may have
pathogenic potential in humans without involvement of
additional, replication-enhancing amino acids, although
some of them may facilitate host adaptation or, in combin-
ation with PB2 627K, further increase the virulence. It will
be of interest to passage H7N7/03 viruses in ferrets to
establish whether the PB2 E627K mutant emerges within
a similar small number of passages when viruses are repli-
cating in an human-like α2,6 SIA-rich environment.
Conclusions
This study shows that the PB2 E627K mutation, also
present in the fatal human case virus, can be sufficient
to convert a HPAI H7N7 virus of low virulence into a
variant causing severe disease and death in mice and
ferrets. Our results underline the importance of PB2 627K
in modulating host specificity and pathogenicity in
Figure 4 Replication of H7N7/03 viruses in the upper and lower
respiratory tract of ferrets. A) Ferrets were i.n. inoculated with
107.4 TCID50 of virus and nasal washes collected at 1, 3, 5, 7 and
9 days p.i. were titrated in MDCK cells. Mean virus titers (n=4) are
shown with error bars indicating standard deviations. The dotted
line indicates the lower limit of detection. B) Mean virus titers in
nasal turbinate (NT), trachea and lung tissues collected from ferrets
(n=3) on day 5 p.i. Error bars represent the standard deviations.
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mammals and emphasize the potential risk of HPAI
H7N7 viruses for human health.
Methods
Cells and viruses
Madin-Darby canine kidney (MDCK) cells and VERO
(African green monkey kidney) cells were cultured
in Dulbecco minimal essential medium (DMEM) sup-
plemented with 5% fetal bovine serum (FBS) and antibi-
otics. Quail myoblast (QM5) cells were cultured in
QT35 complete medium (Life Technology) with the
same supplements. The virus used in this study was
A/ch/Netherlands/621557/03, an HPAI H7N7 virus
isolated from chickens on the index farm of the outbreak
in The Netherlands in 2003 [32]. The virus was prop-
agated in embryonated chicken eggs to produce a
virus stock (designated chH7N7). All experimental
work with HPAI virus was performed under BSL3 con-
ditions in the high-containment unit of Central Veterinary
Institute, Lelystad.
RNA isolation, RT-PCR amplification, and DNA sequencing
Viral RNA was isolated from allantoic fluid of infected
chicken eggs using a High Pure Viral RNA kit (Roche)
according to the manufacturer’s protocol. cDNA was
synthesized using Superscript II (Invitrogen) and amplified
by PCR using Z-Taq polymerase (Takara Bio Inc.) and
primers matching the noncoding sequence of each gene
segment. The PCR products were excised from an agarose
gel and then purified using a Zymoclean kit (Zymo
Research) as indicated by the manufacturer. The cDNA of
maH7N7 was sequenced by direct dideoxy-terminated
cycle sequencing using BigDye terminator v1.1 sequencing
kit (Applied Biosystems) and a 3130 genetic analyzer
sequencer (Applied Biosystems). cDNAs of chH7N7 virus
were produced by PCR, isolated and cloned into the
pGEM-T vector (Promega). Sequences were determined
by sequencing at least two different clones obtained from
independent PCR reactions. For sequence alignments the
SeqMan II software (DNAstar) was used.
Mouse experiments
Female, 7 to 9-week-old BALB/c mice were purchased
from Charles River Laboratories. The chH7N7 virus was
serially passaged by intranasal (i.n.) inoculation (50 μl) of
groups of three mice, starting with a dose of 105 TCID50.
After 4 days, the mice were euthanized; their lungs were
pooled and homogenized in PBS to produce a 20% (w/v)
suspension. The clarified suspension was used as inocu-
lum in the next passage using again three mice. After each
passage, a sample of the lung suspension was titrated
in MDCK cells. Three extra mice were inoculated with
the passage 3 (P3) lung homogenate and maintained to
monitor the course of disease. Virus present in the lung
homogenate of P3 was propagated in embryonated chicken
eggs to produce a virus stock (designated maH7N7) for
use in further experiments.
In the next experiment, the 50% mouse lethal dose
(MLD50) was determined by inoculating four groups of
10 BALB/c mice (female, 7 weeks of age) with increasing
doses of maH7N7 virus. For comparison, two other groups
of 10 mice were inoculated with different doses of chH7N7
virus. Survival and body weights were recorded daily
during 14 days.
Chicken experiment
The pathogenicity of maH7N7 was determined in 5 SPF
white Leghorn chickens (Charles River Laboratories) of
6 weeks of age. These birds were inoculated with 0.2 ml
of diluted allantoic fluid (0.1 ml intranasally [IN] and
0.1 ml intratracheally [IT]) containing 105 TCID50 of virus
and observed daily for clinical signs over a period of
10 days. The birds received a score of 0 if they appeared
normal, 1 if they were ill, 2 if they were severely ill and
3 if they were dead. The IN/IT pathogenicity index was
calculated as the mean score per bird per observation.
Table 3 Virus recovery from organ tissues of ferrets
Virus titers in organs collected from ferrets on day 5 p.i.a
Virus Ferret NTb Tr L1c L2 L3 L4 Ileum Jejun Kidney Liver Spleen Heart Brain
chH7N7 #1 4.1 4.3 2.4 5.0 2.4 2.6 − − − − − − −
#2 nd 3.7 2.4 2.4 2.4 4.9 − − − − − − 2.5
#3 3.2 2.7 4.8 4.7 2.4 3.2 − − − − − − −
maH7N7 #1 5.6 5.1 3.8 4.4 5.2 4.0 − − − − − − −
#2 3.4 5.7 6.3 6.3 6.3 6.8 3.0 3.4 − 2.5 − 2.7 3.0
#3 3.2 5.7 6.2 7.0 7.4 5.9 2.7 − 2.5 − 2.6 3.0 −
aVirus titers expressed as log10 TCID50 per gram tissue.
bNT = nasal turbinate; Tr = trachea; Jejun = jejunum.
cLung tissues were sampled from left cranial (L1), right cranial (L2), left caudal (L3) and right caudal (L4) lobes.
nd = not determined; − = <2.4 log10 TCID50/g.
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Ferret experiment
For this experiment, 21 male ferrets of approximately one
year of age were purchased from a local breeder. All
ferrets had been tested seronegative for H7N7/03 influenza
virus and circulating influenza A viruses, but possessed
HI antibodies (ranging from 20 to 80) against circulating in-
fluenza B/Brisbane/60/2008 virus. After an acclimatization
period of one week, groups of 7 ferrets were anaesthetized
by intramuscular injection of medetomidine (0.1 mg/kg)
and inoculated i.n. with 107.4 TCID50 of virus (0.5 ml). As a
negative control, one group received an equal volume of
sterile allantoic fluid (mock infection). Five days later, three
ferrets per group were sacrificed and examined for gross
pathological lesions. Tissue samples were taken from the
respiratory tract, lungs, visceral organs, heart and brain for
histopathological and virological analyses. The remaining
four animals were weighed daily and observed for signs of
illness during 14 days p.i. Clinical signs were recorded using
a scoring system ranging from 0 (absence of signs) to 3
(severe signs) for activity level [27], sneezing, respiratory
distress, neurological signs, nasal/ocular discharge and
diarrhea. To assess virus shedding, nasal washes were
collected on day 1, 3, 5, 7 and 9 p.i. as previously described
[37]. At the end of the study, all surviving animals were
euthanized and bled. Sera were tested for the presence of
antibodies by standard HI assay using 1% chicken red
blood cells and 4 hemagglutinating units of the chH7N7
virus. Titers were expressed as the reciprocal of the highest
serum dilution inhibiting agglutination. The animals
were necropsied and the same tissue samples were taken
as described above.
Gross pathology and histopathological examination
The organs were examined macroscopically and lesions
described. Gross lung lesions were recorded by indicat-
ing affected areas on a drawing representing all lung
lobes. For histopathology, organ tissues were fixed in
10% neutral buffered formalin, embedded in paraffin and
sectioned into 5 μm-slides. The sections were stained
with hematoxylin-eosin and examined microscopically
by a pathologist blinded to the treatment of the animals.
The characteristics and degree of histopathological
changes in the lungs were evaluated at 10x objective mag-
nification in 4 to 6 slides per lung in 5 or 6 microscopic
fields each and scored on a scale of 0 to 5 as follows:
0 = absence of changes; 1 = few inflammatory cells in <10%
area in at least one microscopic field; 2–5 = alveolitis,
bronchiolitis or (interstitial) pneumonia in <10%, 10-50%,
50-75% and 75-100% area, respectively, in at least one
microscopic field.
Virus titration
Nasal washes were clarified by low-speed centrifugation
and the supernatants were stored at −70°C until analysis.
Organ tissue samples were weighed, homogenized and
diluted in phosphate buffered saline (PBS) or DMEM
containing antibiotics to prepare 20% (w/v) suspensions.
Clarified organ suspensions were either directly titrated
or stored at −70°C before titrations were performed. Virus
titers were determined by the end-point dilution method
as described [38]. Briefly, 10-fold serial dilutions of the
samples were added to MDCK cell cultures. After two
or three days of incubation at 37°C, the cells were
permeabilized, fixed in 4% paraformaldehyde and subjected
to immunoperoxidase staining [39] using NP-specific
monoclonal antibody HB65 (CVI, Lelystad). Virus titers were
calculated according to Reed and Münch and expressed as
50% tissue culture infectious dose (TCID50).
Plaque assay
Confluent cell monolayers grown in 6-well plates were
washed twice with PBS followed by inoculation with ~50
plaque forming units (PFU) of virus. At 2 h p.i., the
inoculum was removed and the monolayers were covered
with 2 ml culture medium containing 1% methylcellulose.
After 7 days of incubation at 37°C, the cells were fixed and
stained with a solution containing 0.1% (w/v) amido black,
12% acetic acid, 1.6% sodium acetate and 10% glycerol.
After 30 min at room temperature, the overlay was
removed, the cells were rinsed with aqua bidest and
then air-dried. Plaque sizes (in mm2) were determined
by measuring the x and y-axis of 15 (QM5 cells) or 20
(MDCK and VERO cells) randomly chosen plaques as
described previously [40]. Differences in plaque size
between maH7N7 and chH7N7 viruses were analyzed
using the two-sample t-test. P values of < 0.05 were
considered statistically significant.
Virus replication kinetics
Growth rates of the viruses were determined after infection
of MDCK or QM5 cells with viruses at a multiplicity of
infection (m.o.i) of 0.001 TCID50 per cell. At 1 h p.i., the
cells were washed once with PBS and 2 ml infection
medium was added to the cells. Supernatants were
collected after 8, 24, 32, 48, and 72 h of incubation at
37°C and titrated by end-point dilution in MDCK cells.
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